Background: Staphylococcus aureus (SA) is an important pathogen among patients with cystic fibrosis (CF).
Inducible clindamycin resistance (ICR) has been described as a cause of treatment failure in non-CF related infections. The prevalence of ICR among SA from
patients with CF is unknown.